Evidence map›Paper›PMID 31549612›Full record

ArticleThe American journal of tropical medicine and hygiene2019

Progress to Eliminate Trachoma as a Public Health Problem in Amhara National Regional State, Ethiopia: Results of 152 Population-Based Surveys.

Aisha E P Stewart, Mulat Zerihun, Demelash Gessese, Berhanu Melak, Eshetu Sata, Andrew W Nute, Tigist Astale, Tekola Endeshaw, Tesfaye Teferi, Zerihun Tadesse and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Changing hygiene behaviours: a cluster-randomized trial, Ethiopia.Bulletin of the World Health Organization · 2021
    Trial
  5. Targeted Antibiotics for Trachoma: A Cluster-Randomized Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Trachoma.Lancet (London, England) · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Aisha E P StewartThe Carter Center, Atlanta, Georgia.
Mulat ZerihunThe Carter Center, Bahir Dar, Ethiopia.
Demelash GesseseThe Carter Center, Bahir Dar, Ethiopia.
Berhanu MelakThe Carter Center, Bahir Dar, Ethiopia.
Eshetu SataThe Carter Center, Addis Ababa, Ethiopia.
Andrew W NuteThe Carter Center, Atlanta, Georgia.
Tigist AstaleThe Carter Center, Addis Ababa, Ethiopia.
Tekola EndeshawThe Carter Center, Addis Ababa, Ethiopia.
Tesfaye TeferiInternational Trachoma Initiative, Addis Ababa, Ethiopia.
Zerihun TadesseThe Carter Center, Addis Ababa, Ethiopia.
Elizabeth Kelly CallahanThe Carter Center, Atlanta, Georgia.
Melsew ChanyalewAmhara National Regional Health Bureau, Bahir Dar, Ethiopia.
Birhan GaudieDr. Abdu Higher Eye Clinic, Bahir Dar, Ethiopia.
Paul M EmersonInternational Trachoma Initiative, Atlanta, Georgia.
Jonathan D KingWorld Health Organization, Geneva, Switzerland.
Scott D NashThe Carter Center, Atlanta, Georgia.
The Carter Center · ETCarter Center · USAmhara Regional Health Bureau · ETInternational Trachoma Initiative · ETInternational Trachoma Initiative · USWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

At baseline in 2006, Amhara National Regional State, Ethiopia, was the most trachoma-endemic region in the country. Trachoma impact surveys (TIS) were conducted in all districts between 2010 and 2015, following 3-5 years of intervention with the WHO-recommended SAFE (surgery, antibiotics, facial cleanliness, and environmental improvement) strategy. A multistage cluster random sampling design was used to estimate the district-level prevalence of trachoma. In total, 1,887 clusters in 152 districts were surveyed, from which 208,265 individuals from 66,089 households were examined for clinical signs of trachoma. The regional prevalence of trachomatous inflammation-follicular (TF) and trachomatous inflammation-intense among children aged 1-9 years was 25.9% (95% CI: 24.9-26.9) and 5.5% (95% CI: 5.2-6.0), respectively. The prevalence of trachomatous scarring and trachomatous trichiasis among adults aged ≥ 15 years was 12.9% (95% CI: 12.2-13.6) and 3.9% (95% CI: 3.7-4.1), respectively. Among children aged 1-9 years, 76.5% (95% CI: 75.3-77.7) presented with a clean face; 66.2% (95% CI: 64.1-68.2) of households had access to water within 30 minutes round-trip, 48.1% (95% CI: 45.5-50.6) used an improved water source, and 46.2% (95% CI: 44.8-47.5) had evidence of a used latrine. Nine districts had a prevalence of TF below the elimination threshold of 5%. In hyperendemic areas, 3-5 years of implementation of SAFE is insufficient to achieve trachoma elimination as a public health problem; additional years of SAFE and several rounds of TIS will be required before trachoma is eliminated.

Indexed as

Mass ScreeningPublic HealthAdolescentChildChild, PreschoolDisease EradicationEndemic DiseasesEthiopiaFemaleHumansMalePrevalenceSurveys and QuestionnairesTrachomaWorld Health Organization

Identifiers

PMID31549612
PMCPMC6896880
OpenAlexW2977124056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.